The European Conference on Infections in Leukaemia (ECIL-10) guidelines for COVID-19 should take convalescent plasma into proper consideration Summary The upcoming ECIL-10 guidelines for COVID-19 management in leukemia patients should thoroughly evaluate the potential benefits Read More
Impaired autophagy by cepharanthine induces immunogenic cell death and enhances anti-PD-1 response in MSS-type colorectal cancer Summary Cepharanthine, a drug known to impair autophagy, shows promise in enhancing anti-PD-1 immunotherapy for MSS-type colorectal cancer (CRC), Read More
CAR-T cell therapy for cancer: current challenges and future directions Summary CAR-T cell therapy has revolutionized cancer treatment, particularly for hematologic malignancies, by engineering a patient’s immune cells to target and destroy cancer cells. Read More
CAR T cell therapy for children with rheumatic disease: the time is now Summary CAR T-cell therapy, traditionally used for cancer, is showing promise in treating severe, refractory rheumatic diseases in children. These diseases often Read More
Immune-checkpoint targeting drug conjugates: a novel class of promising therapeutic agents for cancer treatment Summary Immune-checkpoint targeting drug conjugates (ICT-DCs) represent a promising new strategy in cancer treatment. These conjugates combine the precision of immune Read More
Rechallenge with immune-checkpoint inhibitors in patients with advanced-stage lung cancer Summary Rechallenge with immune checkpoint inhibitors (ICIs) in advanced lung cancer patients who initially benefited but later progressed is a growing area of interest. Studies Read More
1 Million+ Views and Counting..!
It has been 7 years since it was launched in late July 2018, and it is moving forward. Appreciate all the respected visitors! Please share this site with your friends to push science forward and improve human health.
